Form4insider filings, from the source

SEC Form 4 · accession 0001104659-15-050688

T2 Biosystems, Inc. · TTOO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Period of report
Jul 8, 2015
Accepted (ET)
Jul 10, 2015 · 5:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492674

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF6,F2,F7,F8Jul 8, 2015S282$15.9949D41,273ISee Footnotes
Common StockF6,F3,F7,F8Jul 8, 2015S99$15.9949D59,164ISee Footnotes
Common StockF6,F4,F7,F8Jul 8, 2015S144$15.9949D81,536ISee Footnotes
Common StockF6,F5,F7,F8Jul 8, 2015S14,474$15.9949D2,200,883ISee Footnotes
Common StockF9,F2,F7,F8Jul 9, 2015S282$16.1239D40,991ISee Footnotes
Common StockF9,F3,F7,F8Jul 9, 2015S99$16.1239D59,065ISee Footnotes
Common StockF9,F4,F7,F8Jul 9, 2015S144$16.1239D81,392ISee Footnotes
Common StockF9,F5,F7,F8Jul 9, 2015S14,474$16.1239D2,186,409ISee Footnotes
Common StockF10,F2,F7,F8Jul 10, 2015S282$16.6255D40,709ISee Footnotes
Common StockF10,F3,F7,F8Jul 10, 2015S99$16.6255D58,966ISee Footnotes
Common StockF10,F4,F7,F8Jul 10, 2015S144$16.6255D81,248ISee Footnotes
Common StockF10,F5,F7,F8Jul 10, 2015S14,474$16.6255D2,171,935ISee Footnotes

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses